A detailed history of Affinity Asset Advisors, LLC transactions in Merus N.V. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 161,741 shares of MRUS stock, worth $6.87 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares
161,741
Previous 125,000 29.39%
Holding current value
$6.87 Million
Previous $7.4 Million 9.25%
% of portfolio
1.4%
Previous 1.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$47.19 - $58.84 $1.73 Million - $2.16 Million
36,741 Added 29.39%
161,741 $8.08 Million
Q2 2024

Aug 14, 2024

BUY
$39.81 - $60.2 $4.98 Million - $7.53 Million
125,000 New
125,000 $7.4 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.95B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.